BridgeMD
New treatment option for Non-Anemic Iron Deficiency
Official title Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years)
ClinicalTrials.gov ID: NCT07263529
What this study is testing
What is Oral Elemental Iron (Ferrous Sulfate) 80 mg/day?
Oral Elemental Iron (Ferrous Sulfate) 80 mg/day is an investigational medicine, given as an once-weekly pill taken by mouth, being studied as a potential treatment for non-anemic iron deficiency.
Also referred to as Oral Iron Intervention (1 month).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study investigates the risk of anemia development in women aged 18-55 years with non-anemic iron deficiency and evaluates the clinical effects of oral iron therapy. The study consists of a two-month nutritional intervention phase followed by a one-month oral iron treatment phase.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, women only
You may be able to join if
- Female participants aged 18-55 years (including premenopausal and menopausal women).
- Normal hemoglobin level (≥ 12 g/dL).
- Serum ferritin \< 15 μg/L (WHO criteria for iron deficiency).
- Mentzer index \> 13.
- Normal levels of vitamin B12, folic acid, thyroid hormones (TSH and sT4), and C-reactive protein (CRP \< 5 mg/L).
You likely can't join if
- Pregnancy or postpartum period.
- Acute or chronic infections.
- History or suspicion of malignancy.
- Chronic inflammatory or autoimmune diseases.
- Chronic fatigue syndrome or depressive disorders.
- Chronic kidney disease or renal failure (acute or chronic).
See the full eligibility criteria
- Female participants aged 18-55 years (including premenopausal and menopausal women).
- Normal hemoglobin level (≥ 12 g/dL).
- Serum ferritin \< 15 μg/L (WHO criteria for iron deficiency).
- Mentzer index \> 13.
- Normal levels of vitamin B12, folic acid, thyroid hormones (TSH and sT4), and C-reactive protein (CRP \< 5 mg/L).
- Non-anemic iron deficiency confirmed by laboratory results.
- Good general health and cognitive capacity to provide informed consent.
- Willingness to participate, comply with study procedures, and provide written informed consent.
- Pregnancy or postpartum period.
- Acute or chronic infections.
- History or suspicion of malignancy.
- Chronic inflammatory or autoimmune diseases.
- Chronic fatigue syndrome or depressive disorders.
- Chronic kidney disease or renal failure (acute or chronic).
- Congestive heart failure, ischemic heart disease, or cerebrovascular disease.
- Coagulopathy or clinically significant bleeding tendency.
- Hematological disorders (e.g., thalassemia, hemoglobinopathies).
- Postoperative patients, transplant recipients, or dialysis patients.
- Currently using any form of iron supplementation or treatment.
- Any condition that, in the investigator's opinion, may interfere with the participant's safety or the interpretation of study results.
The study team makes the final eligibility decision.
Where it's taking place
- Kâğıthane, Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kâğıthane, Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.